FDA Approved: BUTORPHANOL TARTRATE — Supplemental Application (Hospira, Inc.)

View source ↗

Summary

FDA approves a supplemental application for butorphanol tartrate from Hospira, indicating changes to the product labeling for the generic.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine
• Pain

Drugs mentioned

• Butorphanol Tartrate (Butorphanol tartrate)

Snippet

SUPPL AP for BUTORPHANOL TARTRATE (BUTORPHANOL TARTRATE)